Approximately 3.6% of patients with Parkinson's disease develop symptoms before age 45.
Early‐onset Parkinson's disease (EOPD) patients have a higher familial recurrence risk than …

Introduction This registry evaluated the 24-month safety and efficacy of levodopa-carbidopa
intestinal gel (LCIG) treatment in advanced Parkinson's disease (PD) patients under routine …

Context 4H or POLR3-related leukodystrophy is an autosomal recessive disorder typically
characterized by hypomyelination, hypodontia, and hypogonadotropic hypogonadism, caused …

Importance Current treatments manage symptoms of Parkinson disease (PD), but no known
treatment slows disease progression. Preclinical and epidemiological studies support the …

Objective To compare posterior subthalamic area deep brain stimulation (PSA-DBS)
performed in the conventional manner against diffusion tensor imaging and tractography (DTIT)-…

A single GAG deletion in the DYT1 gene causes primary early‐onset, generalized torsion
dystonia. The DYT1 protein product, torsinA, belongs to the AAA+ family of proteins. When …

Objective: Relatively little is known about the effects of deep brain stimulation on non-motor
symptoms. The aim of this pilot study was to assess the impact of deep brain stimulation on …

The ϵ‐sarcoglycan gene (SGCE) on human chromosome 7q21 has been reported to be a
major locus for inherited myoclonus–dystonia. Linkage to the SGCE locus has been detected …

We describe two affected individuals in a family with myoclonus–dystonia syndrome complicated
with severe depression. One individual committed suicide. Molecular genetic analysis …

Background Vanishing white matter disease is caused by mutations of the eukaryotic
translation initiation factor 2B (EIF2B) and is a prevalent cause of inherited childhood …